VACCINE

Pediatrics • April 1948
Encephalopathies Following
Prophylactic Pertussis Vaccine
Randolph K. Byers, Frederic C. Moll
Abstract
Inspection of the records of the Children’s Hospital for the past ten years has disclosed 15
instances in which children developed acute cerebral symptoms within a period of hours
after the administration of pertussis vaccine. The children varied between 5 and 18 months
in age and, in so far as it is possible to judge children of this age range, were developing normally
according to histories supplied by their parents. None had had convulsions previously.
Many different lots of vaccine, made by eight different manufacturers over a period of eight
years, were implicated. The inoculations were given throughout the usual geographic range
of children coming to this hospital. All but one, at the time of follow-up or death, showed
evidence of impairment of the nervous system, which might still have been in the healing
stage in three or four.
During the same period about half as many children were seen in the hospital suffering from
the encephalopathy secondary to smallpox vaccination, and about twice as many from the
encephalopathy complicating pertussis itself.
A variety of etiologic considerations were suggested by consideration of the reported cases
and references to the literature. That constitutional factors may have been involved was
suggested by both the preponderance of males as opposed to females, and by the high incidence
of abnormalities of the nervous system in the family histories. The clinical course and
cytologic abnormalities of spinal fluids found in acute cases indicated an encephalopathy.
The literature suggested that this process might have resulted from either the activity of a
specific toxin or from an antigen-antibody response. Against the former of these hypotheses
was the unstable nature of the heretofore recognized toxins which could hardly survive in
properly aged vaccines. The rapid onset of symptoms, occasionally within minutes of the
first injection, seemed strong evidence against the second. The present study has left these
etiologic considerations unanswered, but it has called attention to a risk of the prophylactic
use of pertussis vaccine not hitherto recognized.
“In view of the impressive
evidence of the effectiveness
of prophylactic pertussis vaccine
now accumulating, it seems likely
that babies are safer vaccinated
than not. Further studies should be
made to prove this point definitely,
for the encephalopathy following pertussis
vaccine seems more devastating than the
vast majority of the nervous lesions following
the use of smallpox vaccine.”
In view of the impressive evidence of the effectiveness of prophylactic pertussis vaccine
now accumulating, it seems likely that babies are safer vaccinated than not. Further studies
should be made to prove this point definitely, for the encephalopathy following pertussis
vaccine seems more devastating than the vast majority of the nervous lesions following the
use of smallpox vaccine.
http://pediatrics.aappublications.org/content/1/4/437?sid=0d16c0ef-0e60-4827-883e-d8993
3f51dfc&variant=abstract&sso=1&sso_redirect_count=5&nfstatus=401&nftoken=000000
00-0000-0000-0000-000000000000&nfstatusdescription=ERROR%3A%20No%20local%
20token&nfstatus=401&nftoken=00000000-0000-0000-0000-000000000000&nfstatusdesc
ription=ERROR%3a+No+local+token